We must be 'positive' and 'pragmatic'

This is a preview of subscriber content

Subscribe now to continue reading.

"In a week where the Government has announced over $1 billion in new therapies for hepatitis C, it's probably not the time for companies to complain about access - we should congratulate the Government for the commitment and keep the conversation going," says Janssen's recently appointed managing director, Bruce Goodwin. …

Subscribe now to continue reading.

We must be 'positive' and 'pragmatic'

This is a preview of subscriber content

Latest Video

Most Read

Patient alarm over the potential loss of subsidised access to MS medicines

Minister looks to be sending a very clear message about these therapies and the PBS

The minister is following a tried and tested process, but what is the risk in this new world?

When it comes to negotiating with government, trust actions and not words

New MSD vaccine listed on national program with expanded eligibility

New Stories

Nurse prescribing reform set to expand access to PBS subsidised medicines

Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy

Minister looks to be sending a very clear message about these therapies and the PBS

The end-game of strong-arming companies over prices at the expense of patients and process

Commercial outsourcing emerges as a strategic option to patient access

The minister is following a tried and tested process, but what is the risk in this new world?

Patient alarm over the potential loss of subsidised access to MS medicines

Sign In

We must be 'positive' and 'pragmatic'

This is a preview of subscriber content

Latest Video

Most Read

Patient alarm over the potential loss of subsidised access to MS medicines

Minister looks to be sending a very clear message about these therapies and the PBS

The minister is following a tried and tested process, but what is the risk in this new world?

When it comes to negotiating with government, trust actions and not words

New MSD vaccine listed on national program with expanded eligibility

Follow Us

New Stories

Nurse prescribing reform set to expand access to PBS subsidised medicines

Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy

Minister looks to be sending a very clear message about these therapies and the PBS

The end-game of strong-arming companies over prices at the expense of patients and process

Commercial outsourcing emerges as a strategic option to patient access

The minister is following a tried and tested process, but what is the risk in this new world?

Patient alarm over the potential loss of subsidised access to MS medicines